Sun Pharma Advanced Research Co (NSE:SPARC) 3-Year EBITDA Growth Rate : -32.50% (As of Jun. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co 3-Year EBITDA Growth Rate?

Sun Pharma Advanced Research Co's EBITDA per Share for the three months ended in Jun. 2024 was ₹-2.83.

During the past 3 years, the average EBITDA Per Share Growth Rate was -32.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sun Pharma Advanced Research Co was 25.30% per year. The lowest was -121.00% per year. And the median was -28.40% per year.

Competitive Comparison of Sun Pharma Advanced Research Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharma Advanced Research Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sun Pharma Advanced Research Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharma Advanced Research Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sun Pharma Advanced Research Co's 3-Year EBITDA Growth Rate falls into.

Sun Pharma Advanced Research Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sun Pharma Advanced Research Co (NSE:SPARC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sun Pharma Advanced Research Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharma Advanced Research Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

532872:India

Address

Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093

Website

https://www.sparc.life

Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Sun Pharma Advanced Research Co Headlines

No Headlines